Valuation: Orion Oyj

Market Cap 12.59B 14.12B 11.65B 10.54B 19.87B 1,333B 20.1B 140B 54.82B 701B 52.98B 51.88B 2,232B P/E 2026 *
21.8x
P/E 2027 * 18.6x
Enterprise Value 12.49B 14.02B 11.56B 10.47B 19.72B 1,323B 19.95B 139B 54.41B 695B 52.58B 51.49B 2,216B EV / Sales 2026 *
5.93x
EV / Sales 2027 * 5.15x
Free-Float
90.5%
Yield 2026 *
2.23%
Yield 2027 * 2.46%
1 day+1.76%
1 week+8.58%
Current month+8.12%
1 month+10.25%
3 months+19.48%
6 months+19.56%
Current year+41.16%
1 week 85.75
Extreme 85.75
89.95
1 month 78.75
Extreme 78.75
89.95
Current year 62.7
Extreme 62.7
89.95
1 year 56.5
Extreme 56.5
89.95
3 years 31.86
Extreme 31.86
89.95
5 years 31.86
Extreme 31.86
89.95
10 years 22.57
Extreme 22.57
89.95
Manager TitleAgeSince
Chief Executive Officer 59 01/11/2022
Director of Finance/CFO 50 01/05/2024
Chief Operating Officer 46 01/01/2022
Director TitleAgeSince
Director/Board Member 63 22/03/2017
Director/Board Member 65 22/03/2017
Director/Board Member 66 06/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
8/8/25 Sell

Chief Operating Officer

4,000 0.0122%
4/8/25 Sell

Executive/Senior Manager

71 0.0002%
4/8/25 Sell

Executive/Senior Manager

724 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+1.76%+8.58%+33.11%+142.90% 13.92B
-1.01%+5.13%+58.93%+120.37% 1,144B
-0.61%+1.52%+34.34%+70.28% 625B
-1.48%+0.47%+23.08%+96.78% 511B
+0.54%+8.95%+39.45%+64.02% 377B
+1.07%+1.70%+71.06%+45.02% 366B
+0.30%+6.35%+21.84%+49.62% 291B
-0.03%+6.04%+0.40%+20.94% 262B
-0.14%+2.87%+45.56%+60.53% 237B
-1.88%+0.02%+23.77%+98.00% 194B
Average -0.32%+6.35%+35.15%+76.85% 402.18B
Weighted average by Cap. -0.57%+6.91%+40.76%+81.31%

Financials

2026 *2027 *
Net sales 2.1B 2.36B 1.95B 1.76B 3.32B 223B 3.36B 23.37B 9.17B 117B 8.86B 8.68B 373B 2.38B 2.67B 2.2B 1.99B 3.75B 252B 3.8B 26.39B 10.36B 132B 10.01B 9.8B 422B
Net income 571M 640M 528M 478M 901M 60.43B 912M 6.33B 2.49B 31.77B 2.4B 2.35B 101B 669M 750M 619M 560M 1.06B 70.8B 1.07B 7.42B 2.91B 37.22B 2.81B 2.76B 119B
Net Debt -94.56M -106M -87.55M -79.23M -149M -10.01B -151M -1.05B -412M -5.26B -398M -390M -16.77B -345M -388M -320M -289M -545M -36.57B -552M -3.83B -1.5B -19.22B -1.45B -1.42B -61.25B
Projected Income Statement - Annual - Orion Oyj
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Date Price Change Volume
22/10/26 €89.85 +1.76% 217,923
20/10/26 €88.30 +0.28% 181,326
19/10/26 €88.05 +0.40% 176,335
16/10/26 €87.70 +1.50% 252,768
15/10/26 €86.40 +0.52% 235,433
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Orion Oyj
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
88.30EUR
Average target price
77.33EUR
Spread / Average Target
-12.42%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Orion Oyj
  1. Stock Market
  2. Stocks
  3. ORNBV Stock